A Phase 2 Study Comparing the Occurrence of Actinic Keratoses on the Face in High-Risk Individuals After Cryotherapy + Photodynamic Therapy With Levulan Topical Solution + Blue Light Versus Cryotherapy + Vehicle Topical Solution + Blue Light
Phase of Trial: Phase II
Latest Information Update: 26 Aug 2018
Price : $35 *
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- Sponsors DUSA Pharmaceuticals
- 22 Sep 2016 Status changed from active, no longer recruiting to completed.
- 14 Jul 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 18 Sep 2014 New trial record